| |
EU QUALITY BRANDED GENERIC PHARMACEUTICALS
|
|
| |
 |
|
| |
AEGIS understands the need of an affordable healthcare without compromising in quality. The company has its own brand “Aegis” with a wide range of product portfolio consisting of over a 100 products while having one of the strongest pipelines in the industry. The products address all the major therapeutic areas like cardiovascular and metabolism, antibacterial, central nervous system, analgesic and anti-inflammatory, dermatology, gastrointestinal, respiratory and oncology, including injectables. Aegis’ brand is currently promoted mainly in Asia, Africa and Eastern Europe. The product marketing authorizations (MA) are based on EU dossiers that are often used by the majors of the industry. |
|
| |
CONTRACT MANUFACTURING
|
|
| |

AEGIS cooperates with various European customers including leading multinational pharmaceutical companies with the ability to provide them with tablets, blisters or finished products while specializing in niche market demands.
Manufacturing capabilities:
• Solid dosage forms (capsules, tablets, dry powder for
suspension)
• Blistering
• Semi-automated and automated secondary packing
• Secondary packing of cytotoxic products and cool store
products
|
|
| |
|
|
| |
CONTRACT CO-DEVELOPMENT OF DOSSIERS
|
|
| |
 |
|
| |
The AEGIS formulation development team continuously strives to develop new formulations, improve manufacturing processes efficiency and develop new products. Formulation development is equipped with small scale machinery to undertake pilot batches and validation batches under cGMP conditions.
In many cases Aegis co-developed new molecules with other partners.
|
|
| |
PERFORM STABILITY STUDIES AT ALL CONDITIONS
|
|
| |
 |
|
| |
AEGIS is able to perform stability studies for all conditions, using modern walk-in chambers and modern laboratories. |
|
| |
PERFORM ANALYSIS
|
|
| |
 |
|
| |
The state-of-the-art laboratories have the capability to conduct all analysis required for the development of a product and quality control. AEGIS can carry out cytotoxic analysis in dedicated facility in order to offer the highest possible protection to the employees.
Quality is seen as the collective responsibility on all personnel and management. The company's policy of Total Quality is achieved by the commitment and team effort of all employees in every department. The quality system is based on cGMP, GLP and overall QA program.
|
|
Terms Of Use
| Privacy Statement
Copyright 2010 by DotNetNuke Corporation